K Number
K131081
Device Name
CYBER TM FAMILY
Manufacturer
Date Cleared
2013-07-03

(76 days)

Product Code
Regulation Number
878.4810
AI/MLSaMDIVD (In Vitro Diagnostic)TherapeuticDiagnosticis PCCP AuthorizedThirdparty
Intended Use
The Cyber Tm Family (that Includes Cyber Tm 150, Cyber Tm 180 and Cyber Tm 200) and its accessories are intended for use in surgical procedures using open, laparoscopic incision, resection, abletton, vaporization, coagulation and hemostasis of soft tissue in use in medical specialties including: Urclogy, Gastroentarology, Thoracio Gynecslogy, ENT, Demainly, Plastic Surgery, General Surgary and Arthroscopy. Note; The Cyber Tm 180 and Cyber Tm 200 are only approved for the treatment of BPH when used at power levels greater than 150V.
Device Description
The Cyber Tm Family is laser surgical instrument for use in general and plastic surgery and in dermatology (GEX). In the Cyber Tm Family is installed a single Tm:YAG Laser Source with CW emission at 2.01um with adjustable power from 5 W to the maximum output power (as given below). The laser radiation is delivered to the tissue to be treated through fiber optics. The Cyber Tm Family (that includes Cyber Tm 150, Cyber Tm 150, Cyber Tm 180 and Cyber Tm 200) and its accessories are intended for use in surgical procedures using open, laparoscopic and endoscopic incision, excision, ablation, vaporization, coagulation and hemostasis of soft tissue in use in medical specialties including: Urology, Gastroenterology, Thoracic and Pulmonary, Gynecology, ENT, Dermatology, Plastic Surgery, General Surgery and Arthroscopy.
More Information

Not Found

No
The document describes a laser surgical instrument and its intended uses. There is no mention of AI, ML, image processing, or any other technology that would suggest the incorporation of AI/ML. The performance studies focus on bench testing of tissue effects.

Yes
The device is described as a laser surgical instrument intended for use in various surgical procedures involving soft tissue, directly affecting the body for treatment purposes.

No

Explanation: The device is a laser surgical instrument intended for therapeutic procedures such as incision, excision, ablation, vaporization, coagulation, and hemostasis of soft tissue. It is not designed for diagnosis.

No

The device description clearly states it is a "laser surgical instrument" and describes hardware components like a "Tm:YAG Laser Source" and "fiber optics" for delivering laser radiation. This indicates it is a hardware device, not software-only.

Based on the provided information, this device is not an IVD (In Vitro Diagnostic).

Here's why:

  • Intended Use/Indications for Use: The intended use clearly states the device is for surgical procedures involving incision, resection, ablation, vaporization, coagulation, and hemostasis of soft tissue. These are all direct interventions on the human body.
  • Device Description: The description confirms it's a laser surgical instrument that delivers radiation to tissue through fiber optics. This is a therapeutic device, not a diagnostic one.
  • Lack of IVD Characteristics: There is no mention of the device being used to examine specimens derived from the human body (like blood, urine, tissue samples, etc.) to provide information for diagnosis, monitoring, or screening.

IVD devices are used in vitro (outside the body) to analyze samples. This device is used in vivo (inside the body) for surgical treatment.

N/A

Intended Use / Indications for Use

The Cyber Tm Family (that Includes Cyber Tm 150, Cyber Tm 180 and Cyber Tm 200) and its accessories are intended for use in surgical procedures using open, laparoscopic incision, resection, abletton, vaporization, coagulation and hemostasis of soft tissue in use in medical specialties including: Urclogy, Gastroentarology, Thoracio Gynecslogy, ENT, Demainly, Plastic Surgery, General Surgary and Arthroscopy.

Urology:
Open and endoscopic surgery (incision, resection, eblation, vaporization, coagulation and hemostasis) including:
Urethral Strictures
Bladder Neck Incisions (8NI)
Ablation and resection of Bladder Tumors, Uretheral Turnors and Ureteral Turnors.
Ablation of Benign Prostatic Hypertrophy (BHP),
Transurethral incision of the prostate (TUIP)
Laser Resection of the Prostrate
Laser Enucleation of the Prostate
Laser Ablation of the Prostate
Condylomas
Lesions of external genitalia
Note; The Cyber Tm 180 and Cyber Tm 200 are only approved for the treatment of BPH when used at power levels greater than 150V.

Open and endoscopic gastroenterslogy surgery (incision, essecion, ablation, vaporization, coagulation, coagulation and hemostasis) including:
Appendectomy
Polyps
Biopsy
Gall Bladder calculi
Biliary/Bile duct calculi
Ulcers
Gastric ulcers
Duodenal ulcers
Non Bleeding Ulcers
Pancreatitas
Hemorrhoids
Cholecystectomy
Benign and Malignant Neoplasm
Angiodysplasia
Colorectal cancer
Telangiectasias
Telangiectasias of the Osler-Weber-Renu disease
Vascular Malformation
Gastritis
Esophagitis
Esophageal ulcers
Varices
Colitis
Gastric Erosions

Gynecology:
Open and laparoscopic gynecological surgery (incision, resection, ablation, vaporization, coagnation and homostasis):
Intra-uterine treatment of submucous fibroids
benian endometrial polype: and uterine septum by incision, ablation and or vessel
coagulation
Soft tissue excision procedures such as excisional conization of the cervix

ENT:
Endoscopic endonasal surgery (incision, resection, shiption, vaporization, coagulation and hemostasis of soft tissus) including: Endonasal/sinus Surgery
Partial turbinectomy
Polypectomy
Dacryocystor hinostomy
Frontal Sinusotomy
Ethmoidectorny
Maxillary antrostomy
Functional endoscopic sinus surgery
Lesions or tumors of the oral, nasal, glossal, pharyngeal and laryngeal
Tonsillectomy
Adenoidoctomy

Dermatology and Plastic Surgery:
Incision, excision, resection, abletton, vegatiation and hemostasisof soft, mucosal, fatty and cartlaginous thaus, In therapeutic plastic, dermatologic and aesthetic surgical procedures including:
Basal Cell Carcinomas
Lesion of skin and subcutaneous tissue
Skin tags
Plantar warls

Gonoral Surgery
Open laparoscopic and endoscopic surgery (incision, resection, ablation, vaporization, coagulation and hemostasis) including:
Cholecystectorny
Lysis of adhesion
Appendactorny Blopsy
Skin incision
Tissue dissection
Excision of external turnors and lesions
Complete or partial resection of internal organs, tumors and lesions
Mastectorny
Hepatectomy
Pancreatectomy Splenectomy
Thyroidectomy
Parathyroidectomy
Herniorrhaphy
Tonsillectorny
Lymphadenectomy
Partial Nephrectorny
Pilonidal Cystectorny
Resection of lipoma
Debridement of Decubitus Ulcer Hemorrhoids
Debridement of Statis Ulcer

Thoracic and Pulmonary
Open and endbecopic thoracic and pulmon, excision, excision, resection, ablation, vaportzation, coagulation and hemostasis) of soft tissue
Laryngeal lesions
Airway obstructions including carcinoma
Polyps and granuloma
Palliation of obstructing carcinoma of the tracheobroncial tree

Arthroscopy
Arthroscopy/Orthopedic surgery (excision, ablation and cosgulation of soft and cartileginous (issue);
Ablation of soft and cartilaginous tissue in Minimal Invasive Spinal Surgery including
Percutaneous Laser Disc Decompression/Discectorny
Foreminoplasty
Ablation and coagulation of soft vascular and non vascular tissue in minimally invesive spinal surgery.

Product codes (comma separated list FDA assigned to the subject device)

GEX

Device Description

The Cyber Tm Family is laser surgical instrument for use in general and plastic surgery and in dermatology (GEX).

In the Cyber Tm Family is installed a single Tm:YAG Laser Source with CW emission at 2.01um with adjustable power from 5 W to the maximum output power (as given below). The laser radiation is delivered to the tissue to be treated through fiber optics.

The Cyber Tm Family (that includes Cyber Tm 150, Cyber Tm 150, Cyber Tm 180 and Cyber Tm 200) and its accessories are intended for use in surgical procedures using open, laparoscopic and endoscopic incision, excision, ablation, vaporization, coagulation and hemostasis of soft tissue in use in medical specialties including:

Urology, Gastroenterology, Thoracic and Pulmonary, Gynecology, ENT, Dermatology, Plastic Surgery, General Surgery and Arthroscopy.

Note: the Cyber Tm 180 and Cyber Tm 200 are only approved for the treatment of BPH when used at power levels greater than 150W.

The Cyber Tm Family has the following models (and related main characteristics):

ModelsType of laserWavelengthMin PowerMax Power
Cyber Tm 120 (unmodified) predicate deviceCW Tulium: YAG2.010 μm5 W120 W
Cyber Tm 150 (unmodified) predicate deviceCW Tulium: YAG2.010 μm5 W150W
Cyber Tm 180 (new) modified deviceCW Tulium:YAG2.010 μm5 W180 W
Cyber Tm 200 (new) modified deviceCW Tulium: YAG2.010 μm5 W200 W

The first two models of the Cyber Tm Family, the Cyber Tm 120 and Cyber Tm 150. have been already cleared and represent the unmodified devices (Legally Marketed Devices). The other two, the Cyber Tm 180 and Cyber Tm 200, are the derived from the previous ones.

All models share the same structure, the same components and the same software. The differentation of the models derives only from the factory set of the maximum output power, as detailed in the next section.

The modification of the devices is limited to the Tm:YAG Laser Source that is installed inside Cyber Tm Family.

So all models of the Cyber Tm Family share the same structure, the same components and the same software. The differentation of the models derives only from the factory set of the maximum output power of the laser resonator.

Mentions image processing

Not Found

Mentions AI, DNN, or ML

Not Found

Input Imaging Modality

Not Found

Anatomical Site

Urethral, Bladder, Ureteral, Prostate, External genitalia, Appendix, Polyps, Gall Bladder, Biliary/Bile duct, Stomach, Duodenum, Pancreas, Hemorrhoids, Intestine, Colon, Esophagus, Cervix, Sinuses (Endonasal, Frontal, Ethmoid, Maxillary), Oral, Nasal, Glossal, Pharyngeal, Laryngeal, Tonsils, Adenoids, Skin, Subcutaneous tissue, Internal organs, Breast, Liver, Pancreas, Spleen, Thyroid, Parathyroid, Hernia, Lymph nodes, Kidney, Pilonidal, Lipoma, Decubitus Ulcer, Statis Ulcer, Tracheobronchial tree, Spine.

Indicated Patient Age Range

Not Found

Intended User / Care Setting

Not Found

Description of the training set, sample size, data source, and annotation protocol

Not Found

Description of the test set, sample size, data source, and annotation protocol

Not Found

Summary of Performance Studies (study type, sample size, AUC, MRMC, standalone performance, key results)

The Cyber Tm Family (that includes Cyber Tm 120, Cyber Tm 150, Cyber Tm 180 and Cyber Tm 200) and its accessories have been tested in accordance with:

  • IEC 60601-1:2005
  • IEC 60601-1-2:2005
  • IEC 60601-1-4: 1996 (First Ed.) -+ Am.l: 1999 (Consolidated 1.1 Ed.) -
  • for use with IEO 60601-1 (1988), Amts 1 (1991) and 2 (1995) -
  • IEC 60601-2-22:2005
  • IEC 60825-1:2007

The Cyber Tm Family (that includes Cyber Tm 120, Cyber Tm 150, Cyber Tm 180 and Cyber Tm 200) and its accessories comply with European Medical Device 93/42/EEC.

Moreover a specific bench testing was conducted on the proposed Cyber Tm Family devices to support a determination of substantial equivalence to the predicate device. The depth of thermal injury and coaqulation were measured and compared to the unmodified predicate devices and did not show significant differences. The ablation depth was also measured and found to be of comparable depth, keeping the same power density through the use of different fiber diameter. Other tissue effects such as carbonization were also found to be comparable.

Key Metrics (Sensitivity, Specificity, PPV, NPV, etc.)

Not Found

Predicate Device(s): If the device was cleared using the 510(k) pathway, identify the Predicate Device(s) K/DEN number used to claim substantial equivalence and list them here in a comma separated list exactly as they appear in the text. List the primary predicate first in the list.

K090962, K102749, K110941

Reference Device(s): Identify the Reference Device(s) K/DEN number and list them here in a comma separated list exactly as they appear in the text.

Not Found

Predetermined Change Control Plan (PCCP) - All Relevant Information for the subject device only (e.g. presence / absence, what scope was granted / cleared under the PCCP, any restrictions, etc).

Not Found

§ 878.4810 Laser surgical instrument for use in general and plastic surgery and in dermatology.

(a)
Identification. (1) A carbon dioxide laser for use in general surgery and in dermatology is a laser device intended to cut, destroy, or remove tissue by light energy emitted by carbon dioxide.(2) An argon laser for use in dermatology is a laser device intended to destroy or coagulate tissue by light energy emitted by argon.
(b)
Classification. (1) Class II.(2) Class I for special laser gas mixtures used as a lasing medium for this class of lasers. The devices subject to this paragraph (b)(2) are exempt from the premarket notification procedures in subpart E of part 807 of this chapter, subject to the limitations in § 878.9.

0

K131081

JUL 0 3 2013

7. 510(K) SUMMARY - Device Modification

Introduction:

This document contains the 510(k) Summary for the Cyber Tm Family. The content of this summary is based on the requirements of 21 CFR 807.92(c). This is the first submission for the Cyber Tm Family

Applicant /Quanta System SPA
ManufacturerVia IV Novembre, 116
Name and Address:Solbiate Olona (VA)
Italy, 21058

510(k) Contact Person:

Maurizio Bianchi Regulatory Affairs Manager Quanta System SPA

Email: maurizio.bianchi@guantasystem.com Phone: +39 0331 376797 +39 0331 367815 Fax:

Date Prepared: Device Name:

November 20th, 2012 Cyber Tm Family

21 CFR 878.4810

Cyber

Classification: Class II

Classification Name:

Laser surgical instrument for use in general and plastic surgery and in dermatology.

Regulation Number:

Product Code: GEX

Basis for Submission: Technology, Engineering, and Performance Changes

Legally Marketed Device

The Cyber Tm Family is claimed to be substantially equivalent to these legally marketed devices:

  • Cyber Tm 120 of the Cyber Surgical Laser Family (K090962) Quanta System SpA

  • Cyber Tm 150 (K102749) Quanta System SpA

  • RevoLix Family (K110941) - AllMed System Inc.

Performance Standards:

There are no mandatory performance standards for this device.

1

General Device Description (unmodified predicate devices vs new modified devices):

The Cyber Tm Family is laser surgical instrument for use in general and plastic surgery and in dermatology (GEX).

In the Cyber Tm Family is installed a single Tm:YAG Laser Source with CW emission at 2.01um with adjustable power from 5 W to the maximum output power (as given below). The laser radiation is delivered to the tissue to be treated through fiber optics.

The Cyber Tm Family (that includes Cyber Tm 150, Cyber Tm 150, Cyber Tm 180 and Cyber Tm 200) and its accessories are intended for use in surgical procedures using open, laparoscopic and endoscopic incision, excision, ablation, vaporization, coagulation and hemostasis of soft tissue in use in medical specialties including:

Urology, Gastroenterology, Thoracic and Pulmonary, Gynecology, ENT, Dermatology, Plastic Surgery, General Surgery and Arthroscopy.

Note: the Cyber Tm 180 and Cyber Tm 200 are only approved for the treatment of BPH when used at power levels greater than 150W.

ModelsType of laserWavelengthMin PowerMax Power
Cyber Tm 120 (unmodified) predicate deviceCW Tulium: YAG2.010 μm5 W120 W
Cyber Tm 150 (unmodified) predicate deviceCW Tulium: YAG2.010 μm5 W150W
Cyber Tm 180 (new) modified deviceCW Tulium:YAG2.010 μm5 W180 W
Cyber Tm 200 (new) modified deviceCW Tulium: YAG2.010 μm5 W200 W

The Cyber Tm Family has the following models (and related main characteristics):

The first two models of the Cyber Tm Family, the Cyber Tm 120 and Cyber Tm 150. have been already cleared and represent the unmodified devices (Legally Marketed Devices). The other two, the Cyber Tm 180 and Cyber Tm 200, are the derived from the previous ones.

All models share the same structure, the same components and the same software. The differentation of the models derives only from the factory set of the maximum output power, as detailed in the next section.

Description of the modification:

The first two models of the Cyber Tm Family, the Cyber Tm 120 and Cyber Tm 150, have been already cleared and represent the unmodified devices (Legally Marketed Devices). The other two, the Cyber Tm 180 and Cyber Tm 200, are the derived from the previous ones.

The modification of the devices is limited to the Tm:YAG Laser Source that is installed inside Cyber Tm Family.

So all models of the Cyber Tm Family share the same structure, the same components and the same software. The differentation of the models derives only from the factory set of the maximum output power of the laser resonator.

7-2

2

Summary of Performance and basic Safety testing:

The Cyber Tm Family (that includes Cyber Tm 120, Cyber Tm 150, Cyber Tm 180 and Cyber Tm 200) and its accessories have been tested in accordance with:

  • IEC 60601-1:2005

  • IEC 60601-1-2:2005 ı

  • IEC 60601-1-4: 1996 (First Ed.) -+ Am.l: 1999 (Consolidated 1.1 Ed.) -

  • for use with IEO 60601-1 (1988), Amts 1 (1991) and 2 (1995) -

  • । IEC 60601-2-22:2005

  • ، IEC 60825-1:2007

The Cyber Tm Family (that includes Cyber Tm 120, Cyber Tm 150, Cyber Tm 180 and Cyber Tm 200) and its accessories comply with European Medical Device 93/42/EEC.

Moreover a specific bench testing was conducted on the proposed Cyber Tm Family devices to support a determination of substantial equivalence to the predicate device. The depth of thermal injury and coaqulation were measured and compared to the unmodified predicate devices and did not show significant differences. The ablation depth was also measured and found to be of comparable depth, keeping the same power density through the use of different fiber diameter. Other tissue effects such as carbonization were also found to be comparable.

Indications for Use

The Cyber Tm Family is laser surgical instrument for use in general and plastic surgery and in dermatology (GEX).

In the Cyber Tm Family is installed a single Tm:YAG Laser Source with CW emission at 2010 nm with adjustable power from 5 W to the maximum output power (as qiven below). The laser radiation is delivered to the tissue to be treated through fiber optics.

The Cyber Tm Family (that includes Cyber Tm 150, Cyber Tm 150, Cyber Tm 180 and Cyber Tm 200) and its accessories are intended for use in surgical procedures using open, laparoscopic and endoscopic incision, excision, ablation, vaporization, coagulation and hemostasis of soft tissue in use in medical specialties including:

Urology, Gastroenterology, Thoracic and Pulmonary, Gynecology, ENT, Dermatology, Plastic Surgery, General Surgery and Arthroscopy.

Note: The Cyber Tm 180 and Cyber Tm 200 are only approved for the treatment of BPH when used at power levels greater than 150W

The Cyber Tm Family has the following models:

ModelsType of laserWavelengthMin PowerMax Power
Cyber Tm 120 (unmodified) predicate deviceCW Tulium:YAG2.010 $ \mu $ m5 W120 W
Cyber Tm 150 (unmodified) predicate deviceCW Tulium:YAG2.010 $ \mu $ m5 W150W
Cyber Tm 180 (new) modified deviceCW Tulium:YAG2.010 $ \mu $ m5 W180 W
Cyber Tm 200 (new) modified deviceCW Tulium:YAG2.010 $ \mu $ m5 W200 W

The first two models of the Cyber Tm Family, the Cyber Tm 120 and Cyber Tm 150, have been

3

already cleared and represent the unmodified predicate devices (Legally Marketed Devices). The Cyber Tm 180 and Cyber Tm 200, are the derived from the previous ones. The RevoLix Family (K110941) has been already cleared and is a secondary predicate device (Legally Marketed Devices).

The intended use of the predicate devices (Legally Marketed Devices) are the same as the modified devices.

Substantial Equivalence:

The first two models of the Cyber Tm Family, the Cyber Tm 120 and Cyber Tm 150, have been already cleared and represent the unmodified predicate devices (Legally Marketed Devices). The Cyber Tm 180 and Cyber Tm 200. are the derived from the previous ones.

The RevoLix Family (K110941) has been already cleared and is a secondary predicate device (Legally Marketed Devices).

All models of the Cyber Tm Family share the same structure, the same components and the same software. The modified devices have the same intended use and the same technological characteristics and principles of operation as the unmodified devices. It has been demonstrated that the modified devices of the Cyber Tm Family are safe and effective as the unmodified devices and the predicate devices.

Thus the modified devices included in the Quanta System Cyber Tm Family are substantially equivalent to the previously legally marketed devices.

4

Image /page/4/Picture/0 description: The image shows the logo for the U.S. Department of Health & Human Services. The logo consists of a circular seal with the text "DEPARTMENT OF HEALTH & HUMAN SERVICES - USA" arranged around the perimeter. Inside the circle is a stylized symbol that resembles a bird or a human figure in motion, composed of three curved lines.

DEPARTMENT OF HEALTH & HUMAN SERVICES

Public Health Service

Food and Drug Administration 10903 New Hampshire Avenue Document Control Center - WO66-G609 Silver Spring, MD 20993-002

July 3, 2013

Quanta System Spa % Mr. Maurizio Bianchi Via IV Novembre Nº 116 21058 Solbiate Olona (VA) Italy

Re: K131081

Trade/Device Name: Cyber Tm Family Regulation Number: 21 CFR 878.4810 Regulation Name: Laser surgical instrument for use in general surgery and

plastic surgery and in dermatology

Regulatory Class: Class II Product Code: GEX Dated: June 12, 2013 Received: June 13, 2013

Dear Mr. Bianchi:

We have reviewed your Section 510(k) premarket notification of intent to market the device referenced above and have determined the device is substantially equivalent (for the indications for use stated in the enclosure) to legally marketed predicate devices marketed in interstate commerce prior to May 28, 1976, the enactment date of the Medical Device Amendments, or to devices that have been reclassified in accordance with the provisions of the Federal Food. Drug. and Cosmetic Act (Act) that do not require approval of a premarket approval application (PMA). You may, therefore, market the device, subject to the general controls provisions of the Act. The general controls provisions of the Act include requirements for annual registration, listing of devices, good manufacturing practice, labeling, and prohibitions against misbranding and adulteration. Please note: CDRH does not evaluate information related to contract liability warranties. We remind you; however, that device labeling must be truthful and not misleading.

If your device is classified (see above) into either class II (Special Controls) or class III (PMA), it may be subject to additional controls. Existing major regulations affecting your device can be found in the Code of Federal Regulations, Title 21, Parts 800 to 898. In addition, FDA may publish further announcements concerning your device in the Federal Register.

Please be advised that FDA's issuance of a substantial equivalence determination does not mean that FDA has made a determination that your device complies with other requirements of the Act or any Federal statutes and regulations administered by other Federal agencies. You must

5

Page 2 - Mr. Maurizio Bianchi

comply with all the Act's requirements, including, but not limited to: registration and listing (21 CFR Part 807); labeling (21 CFR Part 801); medical device reporting of medical device-related adverse events) (21 CFR 803); good manufacturing practice requirements as set forth in the quality systems (QS) regulation (21 CFR Part 820); and if applicable, the electronic product radiation control provisions (Sections 531-542 of the Act); 21 CFR 1000-1050.

If you desire specific advice for your device on our labeling regulation (21 CFR Part 801), please go to http://www.fda.gov/AboutFDA/CentersOffices/CDRHOffices/ucm 1 1 5809.htm for the Center for Devices and Radiological Health's (CDRH's) Office of Compliance. Also, please note the regulation entitled, "Misbranding by reference to premarket notification" (21CFR Part 807.97). For questions regarding the reporting of adverse events under the MDR regulation (21 CFR Part 803), please go to

http://www.fda.gov/MedicalDevices/Safety/ReportaProblem/default.htm for the CDRH's Office of Surveillance and Biometrics/Division of Postmarket Surveillance.

You may obtain other general information on your responsibilities under the Act from the Division of Small Manufacturers, International and Consumer Assistance at its toll-free number (800) 638-2041 or (301) 796-7100 or at its Internet address http://www.fda.gov/MedicalDevices/ResourcesforYou/Industry/default.htm.

Sincerely yours,

Mark N. Melkerson -S

  • Mark N. Melkerson Acting Director Division of Surgical Devices Office of Device Evaluation Center for Devices and Radiological Health
    Enclosure

6

510{k) Number (if known): K131081

Device Name: Cyber Tm Family

Indications for Use:

The Cyber Tm Family (that Includes Cyber Tm 150, Cyber Tm 180 and Cyber Tm 200) and its accessories are intended for use in surgical procedures using open, laparoscopic incision, resection, abletton, vaporization, coagulation and hemostasis of soft tissue in use in medical specialties including: Urclogy, Gastroentarology, Thoracio Gynecslogy, ENT, Demainly, Plastic Surgery, General Surgary and Arthroscopy.

Urology:

Open and endoscopic surgery (incision, resection, eblation, vaporization, coagulation and hemostasis) including:

Urethral Strictures

Bladder Neck Incisions (8NI)

Ablation and resection of Bladder Tumors, Uretheral Turnors and Ureteral Turnors.

  • Ablation of Benign Prostatic Hypertrophy (BHP),
  • Transurethral incision of the prostate (TUIP)
  • Laser Resection of the Prostrate
  • Laser Enucleation of the Prostate
  • Laser Ablation of the Prostate
  • Condylomas
  • Lesions of external genitalia

Note; The Cyber Tm 180 and Cyber Tm 200 are only approved for the treatment of BPH when used at power levels greater than 150V.

Prescription Use (Part 21 C.F.R. 801 Subpart D) AND/OR

Over-The-Counter Use (21 C.F.R. 807 Subpart C)

(PLEASE DO NOT WRITE BELOW THIS LINE - CONTINUE ON ANOTHER PAGE IF NEEDED) C-ncurrence of CDRH, Office of Device Evaluation (ODE) Neil R Ogden … 2013.06.27 115:35:22 -04'00'

(Division Sign-Off) for MXM

Division of Surgical Devices

510(k) Number K131081

Pag 1 of 5

6-2

7

510(k) Number (if known): K131081

Device Name: Cyber Tm Family Indications for Use: continued

Open and endoscopic gastroenterslogy surgery (incision, essecion, ablation, vaporization, coagulation, coagulation and hemostasis) including:

Appendectomy
Polyps
Biopsy
Gall Bladder calculi
Biliary/Bile duct calculi
Ulcers
Gastric ulcers
Duodenal ulcers
Non Bleeding Ulcers
Pancreatitas
Hemorrhoids
Cholecystectomy
Benign and Malignant Neoplasm
Angiodysplasia
Colorectal cancer
Telangiectasias
Telangiectasias of the Osler-Weber-Renu disease
Vascular Malformation
Gastritis
Esophagitis
Esophageal ulcers
Varices
Colitis
  • Gastric Erosions
    Prescription Use (Part 21 C.F.R. 801 Subpart D) AND/OR

Over-The-Counter Use (21 C.F.R. 807 Subpart C)

(PLEASE DO NOT WRITE BELOW THIS LINE - CONTINUE ON ANOTHER PAGE IF NEEDED) Concurrence of CDRH, Office of Device Evaluation (ODE)

(Division Sign-Off) for MXM

Division of Surgical Devices

510(k) Number K131081

Pag_2 of 5

8

510(k) Number (if known): K131081

Device Name: Cyber Tm Family

Indications for Use: continued

Gynecology:

Open and laparoscopic gynecological surgery (incision, resection, ablation, vaporization, coagnation and homostasis):

  • Intra-uterine treatment of submucous fibroids
  • benian endometrial polype: and uterine septum by incision, ablation and or vessel
  • coagulation
  • Soft tissue excision procedures such as excisional conization of the cervix

ENT:

Endoscopic endonasal surgery (incision, resection, shiption, vaporization, coagulation and hemostasis of soft tissus) including: Endonasal/sinus Surgery

  • Partial turbinectomy
  • Polypectomy
  • Dacryocystor hinostomy
  • Frontal Sinusotomy
  • Ethmoidectorny
  • Maxillary antrostomy
  • Functional endoscopic sinus surgery
  • Lesions or tumors of the oral, nasal, glossal, pharyngeal and laryngeal
  • Tonsillectomy
  • Adenoidoctomy

Dermatology and Plastic Surgery:

Incision, excision, resection, abletton, vegatiation and hemostasisof soft, mucosal, fatty and cartlaginous thaus, In therapeutic plastic, dermatologic and aesthetic surgical procedures including:

  • Basal Cell Carcinomas
    • Lesion of skin and subcutaneous tissue
    • Skin tags
    • Plantar warls

Prescription Use (Part 21 C.F.R. 801 Subpart D)

AND/OR

Over-The-Counter Use (21 C.F.R. 807 Subpart C)

(PLEASE DO NOT WRITE BELOW THIS LINE - CONTINUE ON ANOTHER PAGE IF NEEDED) Concurrence of CDRH, Office of Device Evaluation (ODE)

(Division Sign-Off) for MXM

Division of Surgical Devices

510(k) Number K131081

Pag 3 of 5

e-4

9

510(k) Number (if known): K131081

Device Name: Cyber Tm Family

Indications for Use: continued

Gonoral Surgery

Open laparoscopic and endoscopic surgery (incision, resection, ablation, vaporization, coagulation and hemostasis) including:

  • Cholecystectorny
  • Lysis of adhesion
  • Appendactorny Blopsy
  • Skin incision
  • Tissue dissection
  • Excision of external turnors and lesions
  • Complete or partial resection of internal organs, tumors and lesions
  • Mastectorny
  • Hepatectomy
  • Pancreatectomy Splenectomy
  • Thyroidectomy
  • Parathyroidectomy
  • Herniorrhaphy
  • Tonsillectorny
  • Lymphadenectomy
  • Partial Nephrectorny
  • Pilonidal Cystectorny
  • Resection of lipoma
  • Debridement of Decubitus Ulcer Hemorrhoids
    • Debridement of Statis Ulcer

Prescription Use (Part 21 C.F.R. 801 Subpart D)

AND/OR

Over-The-Counter Use (21 C.F.R. 807 Subpart C)

(PLEASE DO NOT WRITE BELOW THIS LINE - CONTINUE ON ANOTHER PAGE IF NEEDED) Concurrence of CDRH, Office of Device Evaluation (ODE)

(Division Sign-Off) for MXM

Division of Surgical Devices

510{k} Number K131081

Pag 4 of 5

10

510(k) Number (if known): K131081

Device Name: Cyber Tm Family

Indications for Use: continued

Thoracic and Pulmonary

Open and endbecopic thoracic and pulmon, excision, excision, resection, ablation, vaportzation, coagulation and hemostasis) of soft tissue

  • Laryngeal lesions
    • Airway obstructions including carcinoma
  • Polyps and granuloma
  • Palliation of obstructing carcinoma of the tracheobroncial tree

Arthroscopy

Arthroscopy/Orthopedic surgery (excision, ablation and cosgulation of soft and cartileginous (issue);

  • Ablation of soft and cartilaginous tissue in Minimal Invasive Spinal Surgery including
  • Percutaneous Laser Disc Decompression/Discectorny
  • Foreminoplasty
  • Ablation and coagulation of soft vascular and non vascular tissue in minimally invesive spinal surgery.

Prescription Use (Part 21 C.F.R. 801 Subpart D) AND/OR

Over-The-Counter Use (21 C.F.R. 807 Subpart C)

(PLEASE DO NOT WRITE BELOW THIS LINE - CONTINUE ON ANOTHER PAGE IF NEEDED) Concurrence of CDRH, Office of Device Evaluation (ODE)

(Division Sign-Off) for MXM

Division of Surgical Devices

510(k) Number K131081

Pag_5_of_5